Spanish interdisciplinary committee for cardiovascular disease prevention and the Spanish society of cardiology position statement on dyslipidemia management. Differences between the European and American guidelines;Posicionamiento del Comité Español Interdisciplinario de Prevención Cardiovascular y la Sociedad Española de Cardiología en el tratamiento de las dislipemias. Divergencia entre las guías europea y estadounidense

Revista Espanola de Cardiologia

Volumn 67, Issue 11, 2014, Pages 913-919

  Lobos Bejarano, José María ^a,b   Galve, Enrique ^c   Royo Bordonada, Miguel Ángel ^a,d   Alegría Ezquerra, Eduardo ^c   Armario, Pedro ^a,e   Brotons Cuixart, Carlos ^b   Camafort Babkowski, Miguel ^a,f   Cordero Fort, Alberto ^c   Maiques Galán, Antonio ^a,g   Mantilla Morató, Teresa ^b   Pérez Pérez, Antonio ^a,h   Pedro Botet, Juan ⁱ   Villar Álvarez, Fernando ^a,i   González Juanatey, José Ramón ^c  

^a Sociedad Española de Medicina Interna   (Spain)

^b MEDICINA FAMILIAR Y COMUNITARIA   (Spain)

^c Nuestra Senora de Guadalupe   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e Sociedad Espanola de Hipertension Liga Espanola de la Lucha Contra la Hipertension Arterial   (Spain)

^f Lôpez Sociedad Espanola de Medicina Intensiva   (Spain)

^g Programa de Actividades Preventivas y de Promoción de la Salud PAPPS   (Spain)

^h Sociedad Española de Diabetes SED   (Spain)

ⁱ Centro de Atención Primaria Mar Báltico   (Spain)

Author keywords

Cardiovascular prevention; Clinical guidelines; Dyslipidemia

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTILIPEMIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DYSLIPIDEMIA; EUROPEAN; FOLLOW UP; HUMAN; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK REDUCTION; SPANIARD; ADULT; AGED; CARDIOLOGY; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; MALE; MIDDLE AGED; SPAIN; STANDARDS;

ADULT; AGED; CARDIOLOGY; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; SPAIN;

EID: 84908331877     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.05.008     Document Type: Article

References (25)

1. P. Guallar-Castillón, M. Gil-Montero, L.M. León-Muñoz, A. Graciani, A. Bayán-Bravo, and J.M. Taboada Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008-2010: el estudio ENRICA Rev Esp Cardiol 65 2012 551 558
2. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
3. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
4. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, M. Verschuren European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 33 2012 1635 1701
5. M. Anguita, E. Alegría, V. Barrios, J.A. Casasnovas, C. Escobar, and M. León Comentarios a las guías de práctica clínica sobre manejo de las dislipemias de la Sociedad Europea de Cardiología y la Sociedad Europea de Aterosclerosis 2011. Un informe del Grupo de Trabajo del Comité de Guías de Práctica Clínica de la Sociedad Española de Cardiología Rev Esp Cardiol 64 2011 1090 1095
6. M.A. Royo-Bordonada, J.M. Lobos Bejarano, F. Villar Álvarez, S. Sans, A. Pérez, and J. Pedro-Botet Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las guías europeas de prevención cardiovascular 2012 Rev Esp Salud Pública 87 2013 103 120
7. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Merz, C.B. Blum, and R.H. Eckel 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 Suppl 2 2014 S1 S45
8. Institute of Medicine (US) Committee Clinical practice guidelines we can trust 2011 National Academies Press Washington
9. D.L. Sackett The arrogance of preventive medicine CMAJ 167 2002 363 364
10. Ž. Reiner Statins in the primary prevention of cardiovascular disease Nat Rev Cardiol 10 2013 453 464
11. National Institute for Health and Care Excellence. Lipid modification. Cardiovascular risk assessment and the modifications of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE guideline. Draft for consultation, February 2014 [citado 25 Mar 2014]. Disponible en: http://www.nice.org.uk/nicemedia/live/13637/66552/66552.pdf
12. F. Civeira, J. Ascaso, and L. Masana Should we forget about low-density lipoprotein cholesterol J Am Coll Cardiol 63 2014 1228 1229
13. International Atherosclerosis Society. Informe de la Sociedad Internacional de Ateroesclerosis: Recomendaciones generales para el tratamiento de las dislipidemias [citado 25 Mar 2014]. Disponible en: http://www.athero.org/download/IASGuidelines-FullText-SPANISH-20140107.pdf
14. S. Ward, M. Lloyd Jones, A. Pandor, M. Holmes, R. Ara, and A. Ryan A systematic review and economic evaluation of statins for the prevention of coronary events Health Technol Assess 11 2007 1 160
15. Informe de utilización de medicamentos U/HLP/V1/17012014. Utilización de medicamentos hipolipemiantes en España durante el periodo 2000-2012. Madrid: Agencia Española de Medicamentos y Productos Sanitarios; 2014 [citado 25 Mar 2014]. Disponible en: http://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/hipolipemiantes-2000-2012.pdf
16. Huerta Caballo A, Molina Ortiz R, Molina Úbeda JJ. Consumo de estatinas en España (2009/2011). Farmacéuticos Comunitarios. 2012; 4 Supl 1 [citado 25 Mar 2014]. Disponible en: http://www.farmaceuticoscomunitarios.org/journal-article/consumo-estatinas-espana-2009-2011
17. D.C. Goff, D.M. Lloyd-Jones, G. Bennett, S. Coady, R.B. D'Agostino, and R. Gibbons 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 Suppl 2 2014 S49 S73
18. P.M. Ridker, and N.R. Cook Refining the American guidelines for prevention of cardiovascular disease - Authors' reply Lancet 383 2014 600
19. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino, K. Williams, B. Neely, and A.D. Sniderman Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 2014 1422 1431
20. J. Vaucher, P. Marques-Vidal, M. Preisig, G. Waeber, and P. Vollenweider Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease Eur Heart J 35 2014 958 959
21. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
22. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
23. Cholesterol Treatment Trialists Collaboration C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, C. Reith, and N. Bhala Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681
24. K.K. Ray, J.J. Kastelein, S.M. Boekholdt, S.J. Nicholls, K.T. Khaw, and C.M. Ballantyne The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011 Eur Heart J 35 2014 960 968
25. K. Kotseva, D. Wood, G. De Backer, D. De Bacquer, K. Pyörälä, U. Keil EUROASPIRE Study Group EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur J Cardiovasc Prev Rehabil 16 2009 121 137